These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 20714130)
1. Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease. Zinellu A; Loriga G; Scanu B; Pisanu E; Sanna M; Deiana L; Satta AE; Carru C Am J Nephrol; 2010; 32(3):242-248. PubMed ID: 20714130 [TBL] [Abstract][Full Text] [Related]
2. Factors affecting S-homocysteinylation of LDL apoprotein B. Zinellu A; Zinellu E; Sotgia S; Formato M; Cherchi GM; Deiana L; Carru C Clin Chem; 2006 Nov; 52(11):2054-9. PubMed ID: 16990421 [TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein S-homocysteinylation is increased in acute myocardial infarction patients. Zinellu A; Sotgia S; Scanu B; Deiana L; Talanas G; Terrosu P; Carru C Clin Biochem; 2012 Mar; 45(4-5):359-62. PubMed ID: 22240067 [TBL] [Abstract][Full Text] [Related]
4. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Ozkan Y; Ozkan E; Simşek B Int J Cardiol; 2002 Mar; 82(3):269-77. PubMed ID: 11911915 [TBL] [Abstract][Full Text] [Related]
5. Homocysteinylation of low-density lipoproteins (LDL) from subjects with Type 1 diabetes: effect on oxidative damage of human endothelial cells. Ferretti G; Bacchetti T; Rabini RA; Vignini A; Nanetti L; Moroni C; Mazzanti L Diabet Med; 2006 Jul; 23(7):808-13. PubMed ID: 16842488 [TBL] [Abstract][Full Text] [Related]
6. Effect of homocysteinylation of low density lipoproteins on lipid peroxidation of human endothelial cells. Ferretti G; Bacchetti T; Moroni C; Vignini A; Nanetti L; Curatola G J Cell Biochem; 2004 May; 92(2):351-60. PubMed ID: 15108360 [TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein. Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834 [TBL] [Abstract][Full Text] [Related]
8. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
9. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Lynch SM; Frei B Biochim Biophys Acta; 1997 Apr; 1345(2):215-21. PubMed ID: 9106501 [TBL] [Abstract][Full Text] [Related]
10. Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients. Seo H; Oh H; Park H; Park M; Jang Y; Lee M Yonsei Med J; 2010 Jul; 51(4):526-33. PubMed ID: 20499417 [TBL] [Abstract][Full Text] [Related]
11. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD. Sjöberg B; Anderstam B; Suliman M; Alvestrand A Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386 [TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ortiz TT; Terreri MT; Caetano M; Souza FS; D'Almeida V; Sarni RO; Hilário MO Ann Nutr Metab; 2013; 63(1-2):77-82. PubMed ID: 23942034 [TBL] [Abstract][Full Text] [Related]
13. Correlation among cystatin C, homocysteine and arteriosclerosis indexes in patients with chronic kidney disease. Chen T; Li Y; Wang J; Wang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1338-1345. PubMed ID: 35232902 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol. Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210 [TBL] [Abstract][Full Text] [Related]
15. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Hortin GL; Seam N; Hoehn GT Clin Chem; 2006 Dec; 52(12):2258-64. PubMed ID: 17068168 [TBL] [Abstract][Full Text] [Related]
16. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. Villa P; Perri C; Suriano R; Cucinelli F; Panunzi S; Ranieri M; Mele C; Lanzone A J Clin Endocrinol Metab; 2005 Aug; 90(8):4622-9. PubMed ID: 15899950 [TBL] [Abstract][Full Text] [Related]
17. Lipid abnormalities in patients with chronic kidney disease. Keane WF; Tomassini JE; Neff DR Contrib Nephrol; 2011; 171():135-142. PubMed ID: 21625102 [TBL] [Abstract][Full Text] [Related]
18. Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins. Ventura P; Panini R; Rosa MC; Gaetti E; Salvioli G Nutr Metab Cardiovasc Dis; 2003 Aug; 13(4):218-26. PubMed ID: 14650354 [TBL] [Abstract][Full Text] [Related]
19. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878 [TBL] [Abstract][Full Text] [Related]
20. N -Acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion. Ventura P; Panini R; Pasini MC; Scarpetta G; Salvioli G Pharmacol Res; 1999 Oct; 40(4):345-50. PubMed ID: 10527647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]